A detailed history of Td Waterhouse Canada Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 1,311 shares of CRSP stock, worth $60,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,311
Previous 1,311 -0.0%
Holding current value
$60,686
Previous $70.7 Million 15.52%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Nov 12, 2024

SELL
$51.17 - $68.18 $4,349 - $5,795
-85 Reduced 6.09%
1,311 $70.7 Million
Q2 2024

Aug 02, 2024

BUY
$51.17 - $68.18 $5,168 - $6,886
101 Added 7.8%
1,396 $123 Million
Q1 2024

May 10, 2024

SELL
$60.67 - $89.12 $9,282 - $13,635
-153 Reduced 10.57%
1,295 $85.3 Million
Q4 2023

Feb 12, 2024

SELL
$38.62 - $72.18 $1,544 - $2,887
-40 Reduced 2.69%
1,448 $90.7 Million
Q3 2023

Nov 13, 2023

SELL
$45.39 - $59.0 $453 - $590
-10 Reduced 0.67%
1,488 $65.7 Million
Q2 2023

Nov 13, 2023

SELL
$43.47 - $67.77 $9,563 - $14,909
-220 Reduced 12.81%
1,498 $87.3 Million
Q1 2023

Nov 13, 2023

SELL
$41.0 - $56.12 $3,321 - $4,545
-81 Reduced 4.5%
1,718 $80.5 Million
Q4 2022

Nov 13, 2023

SELL
$39.19 - $65.67 $3,997 - $6,698
-102 Reduced 5.37%
1,799 $76.4 Million
Q3 2022

Nov 13, 2023

SELL
$61.1 - $83.78 $143,218 - $196,380
-2,344 Reduced 55.22%
1,901 $128 Million
Q2 2022

Nov 13, 2023

BUY
$43.23 - $73.83 $4,106 - $7,013
95 Added 2.29%
4,245 $273 Million
Q1 2022

Nov 13, 2023

BUY
$53.19 - $79.24 $138,825 - $206,816
2,610 Added 169.48%
4,150 $277 Million
Q4 2021

Nov 13, 2023

BUY
$70.09 - $111.29 $107,938 - $171,386
1,540 New
1,540 $115 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.